Northcoast Research Analysts Reduce Earnings Estimates for ZELTIQ Aesthetics, Inc. (ZLTQ)

ZELTIQ Aesthetics, Inc. (NASDAQ:ZLTQ) – Analysts at Northcoast Research dropped their Q4 2017 earnings per share (EPS) estimates for shares of ZELTIQ Aesthetics in a research note issued to investors on Tuesday. Northcoast Research analyst E. Snyder now anticipates that the firm will post earnings of $0.22 per share for the quarter, down from their prior forecast of $0.28. Northcoast Research has a “Neutral” rating on the stock.

Several other analysts have also recently weighed in on ZLTQ. Brean Capital restated a “buy” rating on shares of ZELTIQ Aesthetics in a research report on Monday, October 24th. Zacks Investment Research upgraded shares of ZELTIQ Aesthetics from a “hold” rating to a “buy” rating and set a $41.00 price objective on the stock in a research report on Wednesday, October 26th. Canaccord Genuity increased their target price on shares of ZELTIQ Aesthetics from $41.00 to $45.00 and gave the company a “buy” rating in a report on Thursday, November 10th. Aegis began coverage on shares of ZELTIQ Aesthetics in a report on Wednesday, December 7th. They set a “buy” rating and a $51.00 target price on the stock. Finally, Maxim Group increased their target price on shares of ZELTIQ Aesthetics from $48.00 to $58.00 and gave the company a “buy” rating in a report on Wednesday, January 4th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and three have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $44.60.

Earnings History and Estimates for ZELTIQ Aesthetics (NASDAQ:ZLTQ)

This news story was reported by WKRB News and is the property of of WKRB News. If you are accessing this news story on another domain, it was illegally copied and reposted in violation of US & international copyright and trademark laws. The legal version of this news story can be accessed at http://www.wkrb13.com/markets/1981685/northcoast-research-analysts-reduce-earnings-estimates-for-zeltiq-aesthetics-inc-zltq.html.

Shares of ZELTIQ Aesthetics (NASDAQ:ZLTQ) traded down 0.13% during trading on Wednesday, hitting $55.62. 1,486,978 shares of the stock traded hands. ZELTIQ Aesthetics has a 12 month low of $20.00 and a 12 month high of $56.18. The company has a 50 day moving average price of $44.91 and a 200 day moving average price of $40.59. The firm has a market cap of $2.22 billion, a price-to-earnings ratio of 71.77 and a beta of 1.01.

In other ZELTIQ Aesthetics news, insider Keith J. Sullivan sold 8,000 shares of the firm’s stock in a transaction on Monday, December 5th. The shares were sold at an average price of $43.78, for a total value of $350,240.00. Following the sale, the insider now owns 87,198 shares of the company’s stock, valued at approximately $3,817,528.44. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, VP Carl Lamm sold 21,600 shares of the firm’s stock in a transaction on Thursday, December 8th. The stock was sold at an average price of $45.00, for a total transaction of $972,000.00. Following the completion of the sale, the vice president now directly owns 34,208 shares in the company, valued at approximately $1,539,360. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 57,600 shares of company stock worth $2,535,120. 15.60% of the stock is owned by insiders.

This news story was reported by WKRB News and is the property of of WKRB News. If you are accessing this news story on another domain, it was illegally copied and reposted in violation of US & international copyright and trademark laws. The legal version of this news story can be accessed at http://www.wkrb13.com/markets/1981685/northcoast-research-analysts-reduce-earnings-estimates-for-zeltiq-aesthetics-inc-zltq.html.

A number of large investors have recently made changes to their positions in the company. Point72 Asset Management L.P. raised its stake in shares of ZELTIQ Aesthetics by 30.7% in the second quarter. Point72 Asset Management L.P. now owns 2,219,762 shares of the company’s stock worth $60,666,000 after buying an additional 521,462 shares during the period. EverPoint Asset Management LLC purchased a new stake in shares of ZELTIQ Aesthetics during the second quarter worth about $15,032,000. Deerfield Management Co. raised its stake in shares of ZELTIQ Aesthetics by 17.4% in the second quarter. Deerfield Management Co. now owns 1,297,000 shares of the company’s stock worth $35,447,000 after buying an additional 192,583 shares during the period. Rosenblum Silverman Sutton S F Inc. CA purchased a new stake in shares of ZELTIQ Aesthetics during the second quarter worth about $1,333,000. Finally, HighTower Advisors LLC raised its stake in shares of ZELTIQ Aesthetics by 9.8% in the second quarter. HighTower Advisors LLC now owns 332,234 shares of the company’s stock worth $9,079,000 after buying an additional 29,767 shares during the period.

ZELTIQ Aesthetics Company Profile

ZELTIQ Aesthetics, Inc is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. Its product, the CoolSculpting System, is designed to reduce stubborn fat bulges. It sell the CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists, and obstetrics and gynecology physicians.

5 Day Chart for NASDAQ:ZLTQ

This story was originally published by WKRB News (http://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://www.wkrb13.com/markets/1981685/northcoast-research-analysts-reduce-earnings-estimates-for-zeltiq-aesthetics-inc-zltq.html

Receive News & Ratings for ZELTIQ Aesthetics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ZELTIQ Aesthetics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

 


Leave a Reply

 
© 2006-2017 WKRB News.